Info
Insider Ownership

Insider Trading & Ownership of Samarth Kulkarni

Location: Cambridge, MA
Summary: The estimated net worth of Samarth Kulkarni is at least $22.8M dollars as of 20 Oct 2025. Samarth Kulkarni is the Chief Executive Officer, Director of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $22.8M.
Signature: /s/ Elizabeth Ryland Waldinger, attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when Samarth Kulkarni files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Samarth Kulkarni

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
CRSP	CRISPR Therapeutics AG	Chief Executive Officer, Director	$22.8M	-$7.55M	-24.9%	16 Oct 2025
BDTX	Black Diamond Therapeutics, Inc.	Director				12 Jun 2025
CNTA	Centessa Pharmaceuticals plc	Director				20 Jun 2025
ORKA	Oruka Therapeutics, Inc.	Director				02 Jun 2025
RPTX	Repare Therapeutics Inc.	Director				17 Jun 2024

Insider Transactions Reported by Samarth Kulkarni:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.